Literature DB >> 22894900

Mutant p53 is a transcriptional co-factor that binds to G-rich regulatory regions of active genes and generates transcriptional plasticity.

Timo Quante1, Benjamin Otto, Marie Brázdová, Iva Kejnovská, Wolfgang Deppert, Genrich V Tolstonog.   

Abstract

The molecular mechanisms underlying mutant p53 (mutp53) "gain-of-function" (GOF) are still insufficiently understood, but there is evidence that mutp53 is a transcriptional regulator that is recruited by specialized transcription factors. Here we analyzed the binding sites of mutp53 and the epigenetic status of mutp53-regulated genes that had been identified by global expression profiling upon depletion of endogenous mutp53 (R273H) expression in U251 glioblastoma cells. We found that mutp53 preferentially and autonomously binds to G/C-rich DNA around transcription start sites (TSS) of many genes characterized by active chromatin marks (H3K4me3) and frequently associated with transcription-competent RNA polymerase II. Mutp53-bound regions overlap predominantly with CpG islands and are enriched in G4-motifs that are prone to form G-quadruplex structures. In line, mutp53 binds and stabilizes a well-characterized G-quadruplex structure in vitro. Hence, we assume that binding of mutp53 to G/C-rich DNA regions associated with a large set of cancer-relevant genes is an initial step in their regulation by mutp53. Using GAS1 and HTR2A as model genes, we show that mutp53 affects several parameters of active transcription. Finally, we discuss a dual mode model of mutp53 GOF, which includes both stochastic and deterministic components.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22894900      PMCID: PMC3466528          DOI: 10.4161/cc.21646

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  58 in total

1.  Mutant p53 cooperates with ETS2 to promote etoposide resistance.

Authors:  Phi M Do; Lakshman Varanasi; Songqing Fan; Chunyang Li; Iwona Kubacka; Virginia Newman; Krishna Chauhan; Silvano Rakeem Daniels; Maurizio Boccetta; Michael R Garrett; Runzhao Li; Luis A Martinez
Journal:  Genes Dev       Date:  2012-04-15       Impact factor: 11.361

2.  Profiling of gene expression changes caused by p53 gain-of-function mutant alleles in prostate cancer cells.

Authors:  Clifford G Tepper; Jeffrey P Gregg; Xu-Bao Shi; Ruth L Vinall; Colin A Baron; Philip E Ryan; Pierre-Yves Desprez; Hsing-Jien Kung; Ralph W deVere White
Journal:  Prostate       Date:  2005-12-01       Impact factor: 4.104

3.  Regulation of mutant p53 temperature-sensitive DNA binding.

Authors:  P Friedlander; Y Legros; T Soussi; C Prives
Journal:  J Biol Chem       Date:  1996-10-11       Impact factor: 5.157

4.  An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival.

Authors:  Lance D Miller; Johanna Smeds; Joshy George; Vinsensius B Vega; Liza Vergara; Alexander Ploner; Yudi Pawitan; Per Hall; Sigrid Klaar; Edison T Liu; Jonas Bergh
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-02       Impact factor: 11.205

5.  Regulation of expression of growth arrest-specific genes in mouse fibroblasts.

Authors:  C Ciccarelli; L Philipson; V Sorrentino
Journal:  Mol Cell Biol       Date:  1990-04       Impact factor: 4.272

6.  Modulation of gene expression by tumor-derived p53 mutants.

Authors:  Mariano J Scian; Katherine E R Stagliano; Michelle A Ellis; Sajida Hassan; Melissa Bowman; Michael F Miles; Swati Palit Deb; Sumitra Deb
Journal:  Cancer Res       Date:  2004-10-15       Impact factor: 12.701

7.  Mutant p53 gain of function: differential effects of different p53 mutants on resistance of cultured cells to chemotherapy.

Authors:  G Blandino; A J Levine; M Oren
Journal:  Oncogene       Date:  1999-01-14       Impact factor: 9.867

8.  Activation of c-myc gene expression by tumor-derived p53 mutants requires a discrete C-terminal domain.

Authors:  M W Frazier; X He; J Wang; Z Gu; J L Cleveland; G P Zambetti
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

9.  Transactivation of the EGR1 gene contributes to mutant p53 gain of function.

Authors:  Lilach Weisz; Amir Zalcenstein; Perry Stambolsky; Yehudit Cohen; Naomi Goldfinger; Moshe Oren; Varda Rotter
Journal:  Cancer Res       Date:  2004-11-15       Impact factor: 12.701

10.  Mutant p53 proteins bind DNA in a DNA structure-selective mode.

Authors:  Thomas Göhler; Stefan Jäger; Gabriele Warnecke; Hideyo Yasuda; Ella Kim; Wolfgang Deppert
Journal:  Nucleic Acids Res       Date:  2005-02-18       Impact factor: 16.971

View more
  24 in total

Review 1.  Transposable elements and G-quadruplexes.

Authors:  Eduard Kejnovsky; Viktor Tokan; Matej Lexa
Journal:  Chromosome Res       Date:  2015-09       Impact factor: 5.239

2.  Gain-of-Function Mutant p53 R273H Interacts with Replicating DNA and PARP1 in Breast Cancer.

Authors:  Gu Xiao; Devon Lundine; George K Annor; Jorge Canar; Viola Ellison; Alla Polotskaia; Patrick L Donabedian; Thomas Reiner; Galina F Khramtsova; Olufunmilayo I Olopade; Alexander Mazo; Jill Bargonetti
Journal:  Cancer Res       Date:  2019-11-27       Impact factor: 12.701

3.  Dissecting the pathways that destabilize mutant p53: the proteasome or autophagy?

Authors:  Sujata Choudhury; Vamsi K Kolukula; Anju Preet; Chris Albanese; Maria Laura Avantaggiati
Journal:  Cell Cycle       Date:  2013-03-06       Impact factor: 4.534

Review 4.  The Function of the Mutant p53-R175H in Cancer.

Authors:  Yen-Ting Chiang; Yi-Chung Chien; Yu-Heng Lin; Hui-Hsuan Wu; Dung-Fang Lee; Yung-Luen Yu
Journal:  Cancers (Basel)       Date:  2021-08-13       Impact factor: 6.639

5.  Guanine quadruplexes are formed by specific regions of human transposable elements.

Authors:  Matej Lexa; Pavlina Steflova; Tomas Martinek; Michaela Vorlickova; Boris Vyskot; Eduard Kejnovsky
Journal:  BMC Genomics       Date:  2014-11-27       Impact factor: 3.969

6.  Mutant p53 cooperates with the SWI/SNF chromatin remodeling complex to regulate VEGFR2 in breast cancer cells.

Authors:  Neil T Pfister; Vitalay Fomin; Kausik Regunath; Jeffrey Y Zhou; Wen Zhou; Laxmi Silwal-Pandit; William A Freed-Pastor; Oleg Laptenko; Suat Peng Neo; Jill Bargonetti; Mainul Hoque; Bin Tian; Jayantha Gunaratne; Olav Engebraaten; James L Manley; Anne-Lise Børresen-Dale; Paul M Neilsen; Carol Prives
Journal:  Genes Dev       Date:  2015-06-16       Impact factor: 11.361

Review 7.  DNA and RNA quadruplex-binding proteins.

Authors:  Václav Brázda; Lucia Hároníková; Jack C C Liao; Miroslav Fojta
Journal:  Int J Mol Sci       Date:  2014-09-29       Impact factor: 5.923

8.  p53 is active in murine stem cells and alters the transcriptome in a manner that is reminiscent of mutant p53.

Authors:  H Yan; V Solozobova; P Zhang; O Armant; B Kuehl; G Brenner-Weiss; C Blattner
Journal:  Cell Death Dis       Date:  2015-02-26       Impact factor: 8.469

9.  Preferential binding of hot spot mutant p53 proteins to supercoiled DNA in vitro and in cells.

Authors:  Marie Brázdová; Lucie Navrátilová; Vlastimil Tichý; Kateřina Němcová; Matej Lexa; Roman Hrstka; Petr Pečinka; Matej Adámik; Borivoj Vojtesek; Emil Paleček; Wolfgang Deppert; Miroslav Fojta
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

Review 10.  Mutant p53 in cancer: new functions and therapeutic opportunities.

Authors:  Patricia A J Muller; Karen H Vousden
Journal:  Cancer Cell       Date:  2014-03-17       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.